Classification
Compound class	Antibody

International Nonproprietary Names
INN number	INN
9746	eldelumab

Synonyms

BMS-936557 | MDX-1100

Comments

Eldelumab (BMS-936557 and formerly MDX-1100) is a a fully human monoclonal antibody targeting the chemokine CXCL10 (a.k.a. interferon-γ-inducible protein-10 or IP-10) [1]. It is being investigated for its anti-inflammatory action in autoimmune conditions. BLAST peptide sequence analysis reveals exact matches with heavy and light chain variable regions claimed in patent US8258266, and identify eldelumab as clone 6A5 [1].

Database Links
Specialist databases
IMGT/mAb-DB	463
Other databases
GtoPdb PubChem SID	315661132
Search PubMed clinical trials	eldelumab
Search PubMed titles	eldelumab
Search PubMed titles/abstracts	eldelumab